Cargando…
Enhancing drug property prediction with dual-channel transfer learning based on molecular fragment
BACKGROUND: Accurate prediction of molecular property holds significance in contemporary drug discovery and medical research. Recent advances in AI-driven molecular property prediction have shown promising results. Due to the costly annotation of in vitro and in vivo experiments, transfer learning p...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360281/ https://www.ncbi.nlm.nih.gov/pubmed/37479969 http://dx.doi.org/10.1186/s12859-023-05413-x |
_version_ | 1785076070036275200 |
---|---|
author | Wu, Yue Ni, Xinran Wang, Zhihao Feng, Weike |
author_facet | Wu, Yue Ni, Xinran Wang, Zhihao Feng, Weike |
author_sort | Wu, Yue |
collection | PubMed |
description | BACKGROUND: Accurate prediction of molecular property holds significance in contemporary drug discovery and medical research. Recent advances in AI-driven molecular property prediction have shown promising results. Due to the costly annotation of in vitro and in vivo experiments, transfer learning paradigm has been gaining momentum in extracting general self-supervised information to facilitate neural network learning. However, prior pretraining strategies have overlooked the necessity of explicitly incorporating domain knowledge, especially the molecular fragments, into model design, resulting in the under-exploration of the molecular semantic space. RESULTS: We propose an effective model with FRagment-based dual-channEL pretraining (FREL). Equipped with molecular fragments, FREL comprehensively employs masked autoencoder and contrastive learning to learn intra- and inter-molecule agreement, respectively. We further conduct extensive experiments on ten public datasets to demonstrate its superiority over state-of-the-art models. Further investigations and interpretations manifest the underlying relationship between molecular representations and molecular properties. CONCLUSIONS: Our proposed model FREL achieves state-of-the-art performance on the benchmark datasets, emphasizing the importance of incorporating molecular fragments into model design. The expressiveness of learned molecular representations is also investigated by visualization and correlation analysis. Case studies indicate that the learned molecular representations better capture the drug property variation and fragment semantics. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12859-023-05413-x. |
format | Online Article Text |
id | pubmed-10360281 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-103602812023-07-22 Enhancing drug property prediction with dual-channel transfer learning based on molecular fragment Wu, Yue Ni, Xinran Wang, Zhihao Feng, Weike BMC Bioinformatics Research BACKGROUND: Accurate prediction of molecular property holds significance in contemporary drug discovery and medical research. Recent advances in AI-driven molecular property prediction have shown promising results. Due to the costly annotation of in vitro and in vivo experiments, transfer learning paradigm has been gaining momentum in extracting general self-supervised information to facilitate neural network learning. However, prior pretraining strategies have overlooked the necessity of explicitly incorporating domain knowledge, especially the molecular fragments, into model design, resulting in the under-exploration of the molecular semantic space. RESULTS: We propose an effective model with FRagment-based dual-channEL pretraining (FREL). Equipped with molecular fragments, FREL comprehensively employs masked autoencoder and contrastive learning to learn intra- and inter-molecule agreement, respectively. We further conduct extensive experiments on ten public datasets to demonstrate its superiority over state-of-the-art models. Further investigations and interpretations manifest the underlying relationship between molecular representations and molecular properties. CONCLUSIONS: Our proposed model FREL achieves state-of-the-art performance on the benchmark datasets, emphasizing the importance of incorporating molecular fragments into model design. The expressiveness of learned molecular representations is also investigated by visualization and correlation analysis. Case studies indicate that the learned molecular representations better capture the drug property variation and fragment semantics. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12859-023-05413-x. BioMed Central 2023-07-21 /pmc/articles/PMC10360281/ /pubmed/37479969 http://dx.doi.org/10.1186/s12859-023-05413-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Wu, Yue Ni, Xinran Wang, Zhihao Feng, Weike Enhancing drug property prediction with dual-channel transfer learning based on molecular fragment |
title | Enhancing drug property prediction with dual-channel transfer learning based on molecular fragment |
title_full | Enhancing drug property prediction with dual-channel transfer learning based on molecular fragment |
title_fullStr | Enhancing drug property prediction with dual-channel transfer learning based on molecular fragment |
title_full_unstemmed | Enhancing drug property prediction with dual-channel transfer learning based on molecular fragment |
title_short | Enhancing drug property prediction with dual-channel transfer learning based on molecular fragment |
title_sort | enhancing drug property prediction with dual-channel transfer learning based on molecular fragment |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360281/ https://www.ncbi.nlm.nih.gov/pubmed/37479969 http://dx.doi.org/10.1186/s12859-023-05413-x |
work_keys_str_mv | AT wuyue enhancingdrugpropertypredictionwithdualchanneltransferlearningbasedonmolecularfragment AT nixinran enhancingdrugpropertypredictionwithdualchanneltransferlearningbasedonmolecularfragment AT wangzhihao enhancingdrugpropertypredictionwithdualchanneltransferlearningbasedonmolecularfragment AT fengweike enhancingdrugpropertypredictionwithdualchanneltransferlearningbasedonmolecularfragment |